
Magnolia Regenerative Medicine Review
Magnolia Regenerative Medicine is no longer available as we reviewed it, so this page is kept for reference.
Magnolia Regenerative Medicine: Website no longer loads and is not taking patients. We're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
See our top-rated GLP-1 providers →Magnolia Regenerative Medicine is a Louisiana-based telehealth and clinic practice selling compounded GLP-1s alongside hormone, recovery and cognitive programs. Semaglutide+B12 starts at $99/mo and Tirzepatide+B12 at $179/mo, both offered on monthly or quarterly plans. It is one of the few compounded sellers that publishes its full telehealth state list rather than hiding it behind an intake form, and it also runs two brick-and-mortar clinics for in-person visits.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Magnolia Regenerative Medicine
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology

Magnolia Regenerative Medicine at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- What's included
- Medication
- Availability
- 25 states + DC
- FDA status
- No FDA warning letter on record
How we scored Magnolia Regenerative Medicine
Each dimension is scored algorithmically from Magnolia Regenerative Medicine’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.6/10Magnolia Regenerative Medicine no longer sells GLP-1 treatment, so no current price applies.
Effectiveness25%
8.4/10Magnolia Regenerative Medicine offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.2/10Online intake and platform experience; 5 platform features disclosed.
Trust & Safety15%
8.4/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
7.6/10Magnolia Regenerative Medicine is available in 25 states plus DC.
Support10%
6.2/10Magnolia Regenerative Medicine provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Magnolia Regenerative Medicine review
Last checked August 2026- Confirmed availability in 25 states plus DC
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Magnolia Regenerative Medicine
We walked Magnolia Regenerative Medicine’s public signup flow in August 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick a product from /weight-loss or All Products. Semaglutide+B12 and Tirzepatide+B12 each have their own page showing a "from" price.
- 2Click "Start Intake Form", which hands off to a Wizlo-hosted questionnaire.
- 3Step one is a welcome screen explaining that the answers build a personalized weight-loss profile.
- 4Step two asks for email, first name and last name before any further question or price is shown.
- Entry prices are public: the Semaglutide+B12 and Tirzepatide+B12 pages show "from $99/mo." and "from $179/mo." without any sign-up.
- The price ladder is not public: "Monthly & quarterly options available" and "more options available" are the only detail given before the intake form.
- The intake asks for name and email at 4% progress, earlier than most GLP-1 funnels ask for identity.
- The FAQ answers the state question directly and lists all 26 telehealth states, which is unusually transparent.
- Labs are disclosed as a separate charge with specific prices, rather than left vague.
Magnolia Regenerative Medicine customer support
- Phone
- (337) 831-8220
GLP-1 medications Magnolia Regenerative Medicine offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
What we like
- Publishes its full telehealth state list (26 states plus D.C.) instead of gating it behind an intake form.
- Semaglutide+B12 starts at $99/mo, at the low end of the compounded market.
- Tirzepatide+B12 starts at $179/mo, with monthly and quarterly plan options.
- Publishes a LegitScript seal ID that resolves against LegitScript's CDN, though the badge itself links only to a generic lookup.
- Two Louisiana clinics offer in-person visits alongside the telehealth service.
- Publishes a support phone number and email address directly on every page.
Watch-outs
- The per-dose price ladder appears only after you supply a name and email; the public pages show "from" figures only.
- No compounding pharmacy is named; the site says only "highly accredited, top-tier compounding pharmacies"
- Lab work is billed separately: $89 for the Essential panel, $189 for the Comprehensive panel.
- A strict no-refund policy applies, and the terms state there are no refunds on medications.
- Canceling requires written notice at least 24 hours before the monthly renewal.
- An "As seen in" row shows Bloomberg, Fox Business and NASDAQ logos, none of which link to any coverage.
- A 4.9/5 star rating is displayed with no named review source behind it.
- Louisiana is not on the telehealth list, so in-state readers must use a clinic in person.
Is Magnolia Regenerative Medicine still an option?
Magnolia Regenerative Medicine no longer offers a GLP-1 weight-loss program, so there is nothing to sign up for today. We cannot quote a current price, because none exists. We keep this page online so past users can see what it offered and find a program that still operates.
If you were a Magnolia Regenerative Medicine patient, talk with your prescriber before your remaining supply runs out. That keeps treatment going without a gap or an unsafe restart dose. Then compare current providers on price, medication and state coverage. Our page of Magnolia Regenerative Medicine alternatives lists programs that still operate, and the ranked list of semaglutide providers shows where each one stands. If you need a new prescription, our guide on how to get a GLP-1 prescription walks through the steps.
The Bottom Line
Magnolia Regenerative Medicine is no longer available as we reviewed it, so this page is kept for reference.
Magnolia Regenerative Medicine might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
- If you want built-in coaching and behavior-change support, consider Ro.
- If you live outside its coverage area and need nationwide access, consider CoreAge Rx.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Magnolia Regenerative Medicine review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.